Skip to Main Content

Paper Details

Association of the Time to Immune Checkpoint Inhibitor (ICI) Initiation and Outcomes With Second Line ICI in Patients With Advanced Urothelial Carcinoma.
Clin Genitourin Cancer
5
2022
Advanced Urothelial Carcinoma, ICI, Patients, aUC, patients, platinum
Author NameAffiliation
Neeraj AgarwalUniversity of Utah
Jure MurgicUniversity Hospital Center Sestre Milosrdnice
Alexandra DrakakiDavid Geffen School of Medicine at university of california los angeles
Eric LuDavid Geffen School of Medicine at university of california los angeles
Jonathan L WrightFred Hutchinson Cancer Center, University of Washington
Evan Y YuUniversity of Washington, WA Fred Hutchinson Cancer Center
Bruce MontgomeryUniversity of Washington, WA Fred Hutchinson Cancer Center
  • 1 - 7

Datasets